Evranos Berna, Polat Sefika Burcak, Cuhaci Fatma Neslihan, Baser Husniye, Topaloglu Oya, Kilicarslan Aydan, Kilic Mehmet, Ersoy Reyhan, Cakir Bekir
Department of Endocrinology and Metabolism, Ataturk Education and Research Hospital, Ankara, Turkey.
Faculty of Medicine, Department of Endocrinology and Metabolism, Yildirim Beyazit University, Ankara, Turkey.
Diagn Cytopathol. 2019 May;47(5):412-416. doi: 10.1002/dc.24117. Epub 2018 Nov 29.
The incidence of thyroid cancer is increasing which can be attributed in part to improved ultrasonography (US) methods and increased detection of incidental thyroid carcinomas (ITC). We aimed to compare ITC with nonincidental thyroid carcinomas (NITC) in this study.
Retrospective analyses of 906 individual patients who were operated for benign and malignant thyroid disease and had a final histopathological diagnosis of thyroid carcinoma were enrolled in this study. Preoperative US examination and fine needle aspiration (FNA) biopsy results were evaluated. The tumor foci in thyroidectomy specimens that were not represented in preoperative US or FNA reports were classified as ITC. The tumor foci that match with the lesions defined in US or FNA results were classified as NITC.
Final histology revealed ITC in 326 patients (36%) and NITC in 580 patients (64% Mean age was 51.7 ± 11.11 in ITC group and 48.15 ± 13.1 in NITC group (P < .001). In NITC group 322 (55.5%) of the patients were operated for suspicious cytology while only 29 (8.9%) of the patients in the ITC group were operated because of this indication (P < .001). There were 1301 cancer foci in histopathology specimens. Among all these cancer foci, 434 (33.3%) were detected incidentally and 867 (66.7%) were detected non-incidentally. About 779 (89.9%) of nonincidental cancer foci were papillary cancer (PTC), while all of the incidental cancer foci were PTC. Mean size was 13 mm in NITC group and it was 3 mm in the ITC group and differed significantly between the groups (P < .001). Tumor size was ≤1 cm in 35.2% of the patients with NITC while 98.5% of patients with ITC had tumor ≤1 cm. The occurrence of multinodularity was higher in ITC than the NITC group (P < 001). Median TSH level was higher in patients with NITC than ITC while both were in the reference range (1.53 vs 1.03 μIU/mL, P < .001). The frequency of thyroiditis detected by US, and thyroid peroxidase antibody and thyroglobulin antibody positivities were similar in patients with ITC and NITC (P = .2, P = .86, and P = .26, respectively). The frequencies of capsular invasion (29.1% vs 7.9%), extrathyroidal extension (13% vs 4.2%), multifocality (35.8% vs 24.2%), non-complete resection (9.2% vs 1.8%), and lymph node metastasis (9.5% vs 1.8%) were significantly higher in the NITC group (P < .001, for each). Persistent/recurrent disease in patients with NITC was more frequent than patients with ITC (P = .004). This outcome was similar for cancers measuring ≤1 cm (P = .001).
ITC is often encountered in older patients and frequently determined in early stages with more favorable histopathological features and better prognosis.
甲状腺癌的发病率正在上升,部分原因可归结于超声(US)检查方法的改进以及偶然甲状腺癌(ITC)检出率的增加。本研究旨在比较ITC与非偶然甲状腺癌(NITC)。
本研究纳入了906例因良性和恶性甲状腺疾病接受手术且最终经组织病理学诊断为甲状腺癌的患者,对其进行回顾性分析。评估术前US检查和细针穿刺(FNA)活检结果。甲状腺切除标本中术前US或FNA报告未显示的肿瘤病灶分类为ITC。与US或FNA结果中定义的病变相符的肿瘤病灶分类为NITC。
最终组织学检查显示,326例患者(36%)为ITC,580例患者(64%)为NITC。ITC组的平均年龄为51.7±11.11岁,NITC组为48.15±13.1岁(P<0.001)。在NITC组中,322例(55.5%)患者因可疑细胞学结果接受手术,而ITC组中仅有29例(8.9%)患者因此指征接受手术(P<0.001)。组织病理学标本中有1301个癌灶。在所有这些癌灶中,434个(33.3%)是偶然发现的,867个(66.7%)是非偶然发现的。非偶然癌灶中约779个(89.9%)为乳头状癌(PTC),而所有偶然癌灶均为PTC。NITC组的平均大小为13mm,ITC组为3mm,两组间差异有统计学意义(P<0.001)。NITC组35.2%的患者肿瘤大小≤1cm,而ITC组98.5%的患者肿瘤≤1cm。ITC组多结节的发生率高于NITC组(P<0.001)。NITC组患者的促甲状腺激素(TSH)中位数水平高于ITC组,不过两者均在参考范围内(1.53对1.03μIU/mL,P<0.001)。ITC组和NITC组患者中,US检测到的甲状腺炎频率以及甲状腺过氧化物酶抗体和甲状腺球蛋白抗体阳性率相似(分别为P=0.2、P=0.86和P=0.26)。NITC组的包膜侵犯(29.1%对7.9%)、甲状腺外扩展(13%对4.2%)、多灶性(35.8%对24.2%)、未完全切除(9.2%对1.8%)和淋巴结转移(9.5%对1.8%)频率均显著高于ITC组(每项P<0.001)。NITC组患者持续性/复发性疾病的发生率高于ITC组(P=0.004)。对于肿瘤大小≤1cm的癌症,这一结果相似(P=0.001)。
ITC常见于老年患者,常于早期被发现,具有更有利的组织病理学特征和更好的预后。